The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens

被引：0
|
作者：
Uzma Khan
Helena Huerga
Aamir J. Khan
Carole D. Mitnick
Catherine Hewison
Francis Varaine
Mathieu Bastard
Michael Rich
Molly F. Franke
Sidney Atwood
Palwasha Y. Khan
Kwonjune J. Seung
机构：
[1] Interactive Research and Development (IRD),Field Epidemiology Department
[2] Epicentre,Department of Global Health and Social Medicine
[3] Interactive Research and Development (IRD) Global,Medical Department
[4] Harvard Medical School,Division of Global Health Equity
[5] Médecins Sans Frontières,undefined
[6] Partners In Health,undefined
[7] Brigham and Women’s Hospital,undefined
来源：
BMC Infectious Diseases | / 19卷
关键词：
MDR-TB; Bedaquiline; Delamanid; Safety; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment
    Jeong, Byeong-Ho
    Jeon, Kyeongman
    Park, Hye Yun
    Kwon, O. Jung
    Lee, Kyung Soo
    Kim, Hong Kwan
    Choi, Yong Soo
    Kim, Jhingook
    Huh, Hee Jae
    Lee, Nam Yong
    Koh, Won-Jung
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (11) : 3127 - 3133
  • [42] Could side effects of MDR-TB treatment change the outcome of the disease?
    Snene, Houda
    Daghfous, Hafaoua
    Ben Saad, Soumaya
    Ben Khelifa, Mouna
    Belhadj, Sameh
    Slim, Leila
    Tritar, Fatma
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [43] Impact of social support programme on MDR-TB patients' treatment outcomes
    Testov, Vadim
    Sterlikov, Sergey
    Vasilyeva, Irina
    Erokhin, Vladislav
    Kasayeva, Teresa
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [44] The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events
    Smith, Jonathan P.
    Gandhi, Neel R.
    Shah, N. Sarita
    Mlisana, Koleka
    Moodley, Pravi
    Johnson, Brent A.
    Allana, Salim
    Campbell, Angela
    Nelson, Kristin N.
    Master, Iqbal
    Brust, James C. M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 83 (01) : 47 - 55
  • [45] Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)
    Bonnet, Maryline
    Bastard, Mathieu
    Du Cros, Philipp
    Atadjan, Khamraev
    Kimenye, Kamene
    Khurkhumal, Shazina
    Hayrapetyan, Armen
    Telnov, Alex
    Hewison, Cathy
    Varaine, Francis
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [46] Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study
    Li Shi
    Jingtao Gao
    Mengqiu Gao
    Ping Deng
    Shu Chen
    Minfu He
    Wenjun Feng
    Xiaoyun Yang
    Yunhui Huang
    Fang He
    Yumeng Hu
    Liping Lei
    Xuelian Li
    Juan Du
    Xiaomeng Hu
    Zhi Liu
    Peijun Tang
    Junfeng Han
    Hua Wang
    Yi Han
    Wei Shu
    Yuxian Sun
    Yi Pei
    Yuhong Liu
    Infectious Diseases and Therapy, 2021, 10 : 457 - 470
  • [47] Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
    Tiberi, Simon
    Sotgiu, Giovanni
    D'Ambrosio, Lia
    Centis, Rosella
    Arbex, Marcos Abdo
    Arrascue, Edith Alarcon
    Alffenaar, Jan Willem
    Caminero, Jose A.
    Gaga, Mina
    Gualano, Gina
    Skrahina, Alena
    Solovic, Ivan
    Sulis, Giorgia
    Tadolini, Marina
    Alarcon Guizado, Valentina
    De Lorenzo, Saverio
    Roby Arias, Aurora Jazmin
    Scardigli, Anna
    Akkerman, Onno W.
    Aleksa, Alena
    Artsukevich, Janina
    Auchynka, Vera
    Bonini, Eduardo Henrique
    Chong Marin, Felix Antonio
    Collahuazo Lopez, Lorena
    de Vries, Gerard
    Dore, Simone
    Kunst, Heinke
    Matteelli, Alberto
    Moschos, Charalampos
    Palmieri, Fabrizio
    Papavasileiou, Apostolos
    Payen, Marie-Christine
    Piana, Andrea
    Spanevello, Antonio
    Vargas Vasquez, Dante
    Viggiani, Pietro
    White, Veronica
    Zumla, Alimuddin
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (06) : 1758 - 1766
  • [48] Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study
    Shi, Li
    Gao, Jingtao
    Gao, Mengqiu
    Deng, Ping
    Chen, Shu
    He, Minfu
    Feng, Wenjun
    Yang, Xiaoyun
    Huang, Yunhui
    He, Fang
    Hu, Yumeng
    Lei, Liping
    Li, Xuelian
    Du, Juan
    Hu, Xiaomeng
    Liu, Zhi
    Tang, Peijun
    Han, Junfeng
    Wang, Hua
    Han, Yi
    Shu, Wei
    Sun, Yuxian
    Pei, Yi
    Liu, Yuhong
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 457 - 470
  • [49] Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatment
    Srikrishna, Geetha
    Gupta, Shashank
    Dooley, Kelly E.
    Bishai, William R.
    FUTURE MICROBIOLOGY, 2015, 10 (08) : 1257 - 1260
  • [50] Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study
    Kingsley Lezor Bieh
    Ralf Weigel
    Helen Smith
    BMC Infectious Diseases, 17
12345